ImmunityBio shared a post on X:
”We’ve announced that our initial data shows 100% disease control in 5 out of 5 patients with recurrent glioblastoma after being treated with our ANKTIVA, NK cell therapy plus the Optune Gio device.”
Proceed to the video attached to the post.
More posts featuring ImmunityBio.